Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study

Authors not listed

Istituto Oncologico Veneto IRCCS · 2019

Abstract

The purpose of this study is to evaluate the safety and efficacy of Cabozantinib in the treatment of patients with renal cell carcinoma.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (2019). Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study. <em>Istituto Oncologico Veneto IRCCS</em>. https://clinicaltrials.gov/study/NCT04416646
Vancouver
Anonymous. Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study. Istituto Oncologico Veneto IRCCS. 2019.
BibTeX
@misc{anon2019Caboza, title = {Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study}, author = {Anonymous}, journal = {Istituto Oncologico Veneto IRCCS}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings